[Federal Register Volume 60, Number 38 (Monday, February 27, 1995)]
[Notices]
[Pages 10588-10589]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-4765]



=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Findings of Scientific Misconduct

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the Office of Research Integrity 
(ORI) has made final findings of scientific misconduct in the following 
case:
    Vivian N. Tanner, Cleveland Clinic Foundation: The Division of 
Research Investigations of the Office of Research Integrity (ORI) 
conducted an investigation into possible scientific misconduct on the 
part of Vivian N. Tanner while she was a clinic coordinator for the 
Collaborative Ocular Melanoma Study (COMS) at the Cleveland Clinic 
Foundation (CCF). ORI concluded that Ms. Tanner committed scientific 
misconduct by falsifying and fabricating clinical trial data on 
research data forms related to a multicenter study on the treatment of 
choroidal melanoma, a rare form of eye cancer. Due to these 
falsifications and fabrications, inaccurate clinical data were entered 
into the clinical trial database. These acts were committed over a 
period of several years, were material, and, therefore, were 
[[Page 10589]] potentially detrimental to the study. The CCF COMS 
project has received U.S. Public Health Service support from 1985 to 
the present through subcontract funds from a National Eye Institute 
cooperative agreement award to the COMS Coordinating Center, The Wilmer 
Ophthalmological Institute, The Johns Hopkins Medical Institutions, 
Baltimore, Maryland. Because the COMS is an ongoing study, no 
publications were affected by the falsfified or fabricated data, and no 
clinical treatment has been based on the results of the study.

FOR FURTHER INFORMATION CONTACT: Director, Division of Research 
Investigations, Office of Research Integrity, 301-443-5330.
Lyle W. Bivens,
Director, Office of Research Integrity.
[FR Doc. 95-4765 Filed 2-24-5; 8:45 am]
BILLING CODE 4160-17-P